npj Parkinson's Disease (Oct 2024)

Structural basis of epitope recognition by anti-alpha-synuclein antibodies MJFR14-6-4-2

  • Ilva Liekniņa,
  • Lasse Reimer,
  • Teodors Panteļejevs,
  • Alons Lends,
  • Kristaps Jaudzems,
  • Aadil El-Turabi,
  • Hjalte Gram,
  • Anissa Hammi,
  • Poul Henning Jensen,
  • Kaspars Tārs

DOI
https://doi.org/10.1038/s41531-024-00822-y
Journal volume & issue
Vol. 10, no. 1
pp. 1 – 14

Abstract

Read online

Abstract Alpha-synuclein (α-syn) inclusions in the brain are hallmarks of so-called Lewy body diseases. Lewy bodies contain mainly aggregated α-syn together with some other proteins. Monomeric α-syn lacks a well-defined three-dimensional structure, but it can aggregate into oligomeric and fibrillar amyloid species, which can be detected using specific antibodies. Here we investigate the aggregate specificity of monoclonal MJFR14-6-4-2 antibodies. We conclude that partial masking of epitope in unstructured monomer in combination with a high local concentration of epitopes is the main reason for MJFR14-6-4-2 selectivity towards aggregates. Based on the structural insight, we produced mutant α-syn that when fibrillated is unable to bind MJFR14-6-4-2. Using these fibrils as a tool for seeding cellular α-syn aggregation, provides superior signal/noise ratio for detection of cellular α-syn aggregates by MJFR14-6-4-2. Our data provide a molecular level understanding of specific recognition of toxic amyloid oligomers, which is critical for the development of inhibitors against synucleinopathies.